On air · 1 of 3 networks
Johnson & Johnson | Vision
- jjvision.com
- US
- 5,453 employees
Johnson & Johnson | Vision’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 30. Watch Johnson & Johnson | Vision with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 11 | Checked 29 Oct 2026 | See all 30 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 29 Oct 2026 | Collect them with the API → |
| Recently | 13 | Ads on the Google Ads Transparency Center | Checked 2 Oct 2026 | Collect them with the API → |
Johnson & Johnson | Vision has 11 live LinkedIn ads. Its Facebook page had no active ads on 29 Oct 2026, and we recorded 13 Google ads on 2 Oct 2026.
Latest ads
- LINKEDIN · VIDEOSince 21 Oct 2026
Light is essential for vision, but not all wavelengths contribute equally to visual quality. The shortest wavelengths of light create the most light scatter, which can lead to halos and reduced clarity, especially at night and in low-light conditions.¹˒² TECNIS OptiBlue™ technology was designed with a violet-light filtering approach that selectively attenuates these shortest wavelengths while preserving the optical characteristics patients rely on.²⁻⁴ By reducing light scatter at the source, this technology helps enhance visual clarity in challenging lighting conditions without compromising contrast or color perception.²⁻⁴ Built on 25 years of continuous innovation and material science, TECNIS OptiBlue™ technology represents the platform's commitment to translating biological insights into optical solutions that work in real-world conditions. Discover how TECNIS OptiBlue™ technology enhances the platform: https://lnkd.in/d_8Vx9EK #TECNIS #25YearsOfTECNIS #VisionScience #Ophthalmology #AdvancingVision References: 1.Puell MC, Palomo-Alvarez C (2017) Effects of Light Scatter and Blur on Low-C ontrast Vision and Disk Halo Size. Optom Vis Sci 94 (4): 505-510. REF2019CT4288 2.Chang D, Pastuck T, Rosen R, Hollman S, Babic T et al. (2020) Violet and Blue Light: Impact of high-energy light on vision and health. J Ophthal Stud 3 (2): https://lnkd.in/ddB4JnQC. REF2021OTH4293. 3.Mainster, Martin A. Violet and blue-light blocking intraocular lenses... 2006. REF2014MLT0013 4.Canovas C, Weeber H, Trentacost D, Janakiraman P, Tarantino N et al. (2019) Optical and Visual performance of violet blocking intraocular lenses. Invest Ophthalmol Vis Sci 60 (9): 3717-3717. REF2021OTH4028. The promoted product is a medical device. For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question. ©Johnson & Johnson and its affiliates 2026
- LINKEDIN · VIDEOSince 7 Oct 2026
Intermediate vision matters. TECNIS Eyhance™ IOL was designed to deliver enhanced intermediate vision alongside high-quality distance vision¹⁻³, translating the eye's optical intelligence into a lens that supports modern lifestyles³. With a refractive surface design that's progressive in power from the periphery to the center of the lens⁴, TECNIS Eyhance™ IOL defies monofocal convention while maintaining the proven optical performance and clinical evidence that define the TECNIS™ platform¹⁻⁴,⁵⁻⁷. For surgeons, that means a trusted solution for patients who want more than traditional monofocal performance. For patients, it means vision that feels natural and effortless across the tasks that matter most²,³,⁴⁻⁷. Discover how TECNIS Eyhance™ IOL advances intermediate vision: https://lnkd.in/d_8Vx9EK #TECNIS #25YearsOfTECNIS #VisionScience #Ophthalmology #AdvancingVision References 1. DOF2018CT4015 – Clinical investigation of TECNIS Eyhance™ IOL. 2. Fernández J, et al. Visual and patient-reported outcomes of an enhanced versus monofocal intraocular lenses in cataract surgery: a systematic review and meta-analysis. 2025REF6162. 3. Auffarth GU, Gerl M, Tsai L, Janakiraman DP, Jackson B, Alarcon A, Dick HB; Quantum Study Group. Clinical evaluation of a new monofocal IOL with enhanced intermediate function in patients with cataract. J Cataract Refract Surg. 2021;47(2):184–191. REF2021CT4157. 4. Alarcon A, Canovas C, Koopman B, Weeber H, Auffarth G, Piers P. Enhancing the Intermediate Vision of Monofocal Intraocular Lenses Using a Higher Order Aspheric Optic. J Refract Surg. 2020;36(8):520–527. REF2021CT4086. 5. Alarcon A, Canovas C, Koopman B, Pande MV, Koch DD, Piers P. Optical Bench Evaluation of the Effect of Pupil Size in New Generation Monofocal Intraocular Lenses. BMC Ophthalmol. 2023;23(1):112. REF2023CT4265. 6. Pieh S, Artmayr C, Pai V, Schartmüller D, Kriechbaum K. Through-Focus Response of Extended Depth of Focus Intraocular Lenses. J Refract Surg. 2022;38(8):497–501. REF2022CT4376. 7. Labuz G, Son H-S, Naujokaitis T, et al. Laboratory Investigation of Preclinical Visual-Quality Metrics and Halo-Size in Enhanced Monofocal Intraocular Lenses. Ophthalmol Ther. 2021;10(4):1093–1104. REF2022MLT4077. The promoted product is a medical device. For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question. ©Johnson & Johnson and its affiliates 2026
- LINKEDIN · VIDEOSince 30 Sept 2026
Cataract surgery is the most frequently performed surgical procedure worldwide, with 53 surgeries performed each minute.¹ At this volume of procedure, even small changes may result in reductions in material and packaging usage. SmartLOAD™ Delivery Technology supports these objectives by pairing a reusable inserter with a compact, lightweight single-use cartridge, delivering benefits that amplify with every case. With SmartLOAD™ Delivery Technology, TECNIS™ IOL brings both goals into the same room – pairing the optical quality and precision the platform has stood for over 25 years² with a responsible approach to surgical waste.¹ Explore the full story of TECNIS™ IOL: https://lnkd.in/d_8Vx9EK #TECNIS #25YearsOfTECNIS #VisionScience #Ophthalmology #AdvancingVision #Sustainability References 1.O’Brart D. (2025) The future of cataract surgery. Eye 39;1451-1456. 2.Eppig T, et al. Aberration Correction with Aspheric Intraocular Lenses. 2024REF5180. The promoted product is a medical device. For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question. ©Johnson & Johnson and its affiliates 2026 2026PP11981
- LINKEDIN · VIDEOSince 12 Sept 2026
We're live in London! 🇬🇧 ESCRS 2026 is officially underway. Join us for an opening-day walk-through of the Johnson & Johnson Booth and discover our programme and innovations live at The European Society of Cataract and Refractive Surgeons (ESCRS) 2026. 📅 Explore the full programme here: https://lnkd.in/d_W6XE-2 #ESCRS2026 #JNJVISION #JNJVISIONEMEA #Ophthalmology The promoted products are medical devices. For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question. The promoted products are medical devices. © Johnson & Johnson and its affiliates 2026 2026PP14381
- LINKEDIN · VIDEOSince 10 Sept 2026
What if one lens could combine the strengths of two optical technologies? TECNIS Synergy™ OptiBlue™ IOL was designed as the first hybrid IOL,* integrating diffractive multifocal and extended depth of focus technologies into a single platform.¹* By translating the eye's optical needs into a design that delivers continuous, high-quality vision from near through distance,¹˒⁵ it represents a milestone in presbyopia correction.¹ Built on the same foundation of continuous innovation and clinical evidence that define TECNIS™,¹ this hybrid approach supports patient satisfaction and visual outcomes.¹˒²˒⁴ For surgeons, that means a versatile solution backed by proven performance.¹˒⁶ For patients, it means vision that feels natural across all distances.¹˒⁵ See how TECNIS Synergy™ OptiBlue™ IOL redefines presbyopia correction: https://lnkd.in/dqCQUQ-N References: 2024DOF4002 - TECNIS Odyssey Full Visual Range IOL 1 TECNIS Synergy™ OptiBlue™ IOL w Simplicity DFR00V - eIfU_Z311569E_current revision 2 Eppig T, et al. Aberration Correction with Aspheric Intraocular Lenses. Intechopen.89361. 14 Oct 2019. 2024REF5180. 3 Data on File 150 – Sensar not associated with glistening – literature analysis. REF2014OTH0002. 4 Piers P, et al. Use of adaptive optics to determine the optimal ocular spherical aberration. J Cataract Refract Surg. 2007 Oct;33(10):1721-6. REF2014CT0360. 5 DOF2018CT4007 – Weeber H. Chromatic aberration of the TECNIS Symfony IOL. 24 May 2018. 6 Kahraman G, et al. Intraindividual comparison of capsule behavior of 2 hydrophobic acrylic intraocular lenses during a 5-year follow-up. J Cataract Refract Surg. 2017;43(2):228-233. REF2018CT4047. #TECNIS #25YearsOfTECNIS #VisionScience #Ophthalmology #AdvancingVision For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question. The promoted products are medical devices 2026PP09219
- LINKEDIN · VIDEOSince 10 Sept 2026
Astigmatism correction is only effective if the lens stays where you put it. TECNIS™ Toric IOL and Toric II IOLs were engineered to translate the eye's optical needs into a lens design that delivers remarkable rotational stability and consistent astigmatism correction.³ Built on the same principles of biology-informed optics and continuous innovation that define the TECNIS™ platform, these lenses help surgeons achieve consistent astigmatism correction.³ For patients, that means clearer, more stable vision and reduced dependence on distance glasses.¹,² See how TECNIS™ Toric delivers stability and confidence: https://lnkd.in/d_8Vx9EK #TECNIS #25YearsOfTECNIS #VisionScience #Ophthalmology #AdvancingVision References: 1 Kessel et al. Toric intraocular lens in the correction of astigmatism during cataract surgery. 2025REF5007. 2 FDA – Premarket Approval (PMA): Summary of Safety and Effectiveness Data. TECNIS™ Monofocal 1-Piece Toric IOL. April 15, 2013. REF2018CT4106. 3 Clinical Investigation of Rotational Stability of the TECNIS™ Toric II IOL – From Study NXGT-202-QROS. 20 Aug. 2021. DOF2021CT4019. The promoted products are medical devices. For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question. ©Johnson & Johnson and its affiliates 2026 2026PP11989
6 of 30 adsSign up to see every Johnson & Johnson | Vision ad, filter by format and date, and get alerts on new ones.
See all 30 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.